Pages that link to "Q34250821"
Jump to navigation
Jump to search
The following pages link to Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation (Q34250821):
Displaying 41 items.
- Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3) (Q26783258) (← links)
- Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy (Q28109507) (← links)
- The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents (Q28598004) (← links)
- Hunger and Satiety Gauge Reward Sensitivity (Q30234294) (← links)
- Obesity: Current and potential pharmacotherapeutics and targets (Q30243992) (← links)
- Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers. (Q34195397) (← links)
- Ghrelin-Derived Peptides: A Link between Appetite/Reward, GH Axis, and Psychiatric Disorders? (Q34406857) (← links)
- Development and validation of an UPLC-MS/MS assay for quantitative analysis of the ghrelin receptor inverse agonist PF-5190457 in human or rat plasma and rat brain (Q35842204) (← links)
- Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence (Q35956492) (← links)
- Pharmacotherapy for alcohol use disorder: current and emerging therapies (Q36684437) (← links)
- Genetic variation of the growth hormone secretagogue receptor gene is associated with alcohol use disorders identification test scores and smoking (Q37275601) (← links)
- Serum Insulin Levels Are Reduced by Intravenous Ghrelin Administration but Do Not Correlate with Alcohol Craving in Alcohol-Dependent Individuals (Q37388471) (← links)
- Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models (Q38718932) (← links)
- Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence? (Q38788717) (← links)
- The Leu72Met Polymorphism of the Prepro-ghrelin Gene is Associated With Alcohol Consumption and Subjective Responses to Alcohol: Preliminary Findings (Q38798123) (← links)
- Changes in circulating peptide YY and ghrelin are associated with early smoking relapse. (Q38903735) (← links)
- The gut in the brain: the effects of bariatric surgery on alcohol consumption (Q38941933) (← links)
- Relationship between craving and ghrelin, adiponectin, and resistin levels in patients with alcoholism (Q39022529) (← links)
- Intermittent access to a nutritionally complete high-fat diet attenuates alcohol drinking in rats (Q39081429) (← links)
- Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving (Q41270245) (← links)
- The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice (Q42921582) (← links)
- Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals (Q47603883) (← links)
- Ghrelin is Supressed by Intravenous Alcohol and is Related to Stimulant and Sedative Effects of Alcohol (Q47729412) (← links)
- Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats (Q47791067) (← links)
- Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats. (Q47830426) (← links)
- Effect of vertical sleeve gastrectomy on alcohol consumption and preferences in dietary obese rats and mice: A plausible role for altered ghrelin signaling (Q47930455) (← links)
- Medications for alcohol use disorders: An overview (Q47942161) (← links)
- Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents (Q48099438) (← links)
- New steps for treating alcohol use disorder. (Q52343223) (← links)
- Stress, motivation and the gut-brain axis: A focus on the ghrelin system and alcohol use disorder. (Q54330154) (← links)
- Ghrelin is a persistent biomarker for chronic stress exposure in adolescent rats and humans. (Q55361558) (← links)
- Ghrelin Receptor Antagonism of Methamphetamine-Induced Conditioned Place Preference and Intravenous Self-Administration in Rats (Q59138260) (← links)
- The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study (Q88574413) (← links)
- Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking (Q90024611) (← links)
- Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers (Q90308624) (← links)
- Modulation of Gpr39, a G-protein coupled receptor associated with alcohol use in non-human primates, curbs ethanol intake in mice (Q90893630) (← links)
- Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future (Q92189687) (← links)
- Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach (Q92640574) (← links)
- Alcohol use disorders (Q93068492) (← links)
- Leptin predicts cortical and subcortical gray matter volume recovery in alcohol dependent patients: A longitudinal structural magnetic resonance imaging study (Q94588488) (← links)
- Activation of the amylin pathway modulates cocaine-induced activation of the mesolimbic dopamine system in male mice (Q101469842) (← links)